APO Research
Talk to an analyst

APO RESEARCH · REPORT

Urological Medications

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Urological Medications Industry Growth and Trends Forecast to 2032

2 January 2026112 pages

Choose your research edition.

Industry ResearchUrological Medications Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Urological Medications Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Urological Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Urological Medications Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Urological Medications Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

According to APO Research, the global Urological Medications market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Urological Medications is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Urological Medications is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Urological Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Urological Medications market include Abbott, Novartis, Merck, Lilly, Pfizer, GlaxoSmithKline, AbbVie, Viatris and Sanofi-aventis U.S. LLC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Urological Medications market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Urological Medications market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Urological Medications market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Urological Medications.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Urological Medications market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Urological Medications Market by Company

Abbott

Novartis

Merck

Lilly

Pfizer

GlaxoSmithKline

AbbVie

Viatris

Sanofi-aventis U.S. LLC

Piramal Pharma Solutions

Mallinckrodt

Endo International

Bayer HealthCare Pharmaceuticals

Astellas Pharma

ADVANZ PHARMA

Urological Medications Segment by Type

Anticholinergics

Alpha Blockers

5-Alpha Inhibitors

Others

Urological Medications Segment by Application

OAB

ED

Prostate Cancer

BPH

SUI

Others

Urological Medications Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Urological Medications market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Urological Medications and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Urological Medications.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Urological Medications companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Urological Medications Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Urological Medications Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Urological Medications Market Share by Region (2021-2026) Table 4. Global Urological Medications Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Urological Medications Market Share by Region (2027-2032) Table 6. Global Urological Medications Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Urological Medications Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Urological Medications Market Size Share by Type (2021-2026) Table 9. Global Urological Medications Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Urological Medications Market Size Share Forecasted by Type (2027-2032) Table 11. North America Urological Medications Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Urological Medications Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Urological Medications Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Urological Medications Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Urological Medications Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Urological Medications Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Urological Medications Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Urological Medications Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Urological Medications Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Urological Medications Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Urological Medications Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Urological Medications Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Urological Medications Market Size Share by Application (2021-2026) Table 24. Global Urological Medications Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Urological Medications Market Size Share Forecasted by Application (2027-2032) Table 26. North America Urological Medications Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Urological Medications Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Urological Medications Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Urological Medications Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Urological Medications Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Urological Medications Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Urological Medications Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Urological Medications Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Urological Medications Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Urological Medications Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Urological Medications Industry Trends Table 37. Urological Medications Industry Drivers Table 38. Urological Medications Industry Opportunities and Challenges Table 39. Urological Medications Industry Restraints Table 40. Global Urological Medications Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Urological Medications Revenue Market Share by Company (2021-2026) Table 42. Global Urological Medications Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Urological Medications Key Company Headquarters & Area Served Table 44. Global Urological Medications Company, Product Type & Application Table 45. Global Urological Medications Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Urological Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Abbott Company Information Table 49. Abbott Business Overview Table 50. Abbott Urological Medications Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Abbott Urological Medications Product Portfolio Table 52. Abbott Recent Development Table 53. Novartis Company Information Table 54. Novartis Business Overview Table 55. Novartis Urological Medications Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Novartis Urological Medications Product Portfolio Table 57. Novartis Recent Development Table 58. Merck Company Information Table 59. Merck Business Overview Table 60. Merck Urological Medications Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Merck Urological Medications Product Portfolio Table 62. Merck Recent Development Table 63. Lilly Company Information Table 64. Lilly Business Overview Table 65. Lilly Urological Medications Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Lilly Urological Medications Product Portfolio Table 67. Lilly Recent Development Table 68. Pfizer Company Information Table 69. Pfizer Business Overview Table 70. Pfizer Urological Medications Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Pfizer Urological Medications Product Portfolio Table 72. Pfizer Recent Development Table 73. GlaxoSmithKline Company Information Table 74. GlaxoSmithKline Business Overview Table 75. GlaxoSmithKline Urological Medications Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. GlaxoSmithKline Urological Medications Product Portfolio Table 77. GlaxoSmithKline Recent Development Table 78. AbbVie Company Information Table 79. AbbVie Business Overview Table 80. AbbVie Urological Medications Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. AbbVie Urological Medications Product Portfolio Table 82. AbbVie Recent Development Table 83. Viatris Company Information Table 84. Viatris Business Overview Table 85. Viatris Urological Medications Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Viatris Urological Medications Product Portfolio Table 87. Viatris Recent Development Table 88. Sanofi-aventis U.S. LLC Company Information Table 89. Sanofi-aventis U.S. LLC Business Overview Table 90. Sanofi-aventis U.S. LLC Urological Medications Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Sanofi-aventis U.S. LLC Urological Medications Product Portfolio Table 92. Sanofi-aventis U.S. LLC Recent Development Table 93. Piramal Pharma Solutions Company Information Table 94. Piramal Pharma Solutions Business Overview Table 95. Piramal Pharma Solutions Urological Medications Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Piramal Pharma Solutions Urological Medications Product Portfolio Table 97. Piramal Pharma Solutions Recent Development Table 98. Mallinckrodt Company Information Table 99. Mallinckrodt Business Overview Table 100. Mallinckrodt Urological Medications Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Mallinckrodt Urological Medications Product Portfolio Table 102. Mallinckrodt Recent Development Table 103. Endo International Company Information Table 104. Endo International Business Overview Table 105. Endo International Urological Medications Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Endo International Urological Medications Product Portfolio Table 107. Endo International Recent Development Table 108. Bayer HealthCare Pharmaceuticals Company Information Table 109. Bayer HealthCare Pharmaceuticals Business Overview Table 110. Bayer HealthCare Pharmaceuticals Urological Medications Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Bayer HealthCare Pharmaceuticals Urological Medications Product Portfolio Table 112. Bayer HealthCare Pharmaceuticals Recent Development Table 113. Astellas Pharma Company Information Table 114. Astellas Pharma Business Overview Table 115. Astellas Pharma Urological Medications Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Astellas Pharma Urological Medications Product Portfolio Table 117. Astellas Pharma Recent Development Table 118. ADVANZ PHARMA Company Information Table 119. ADVANZ PHARMA Business Overview Table 120. ADVANZ PHARMA Urological Medications Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. ADVANZ PHARMA Urological Medications Product Portfolio Table 122. ADVANZ PHARMA Recent Development Table 123. North America Urological Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Urological Medications Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Urological Medications Market Share by Country (2021-2026) Table 126. North America Urological Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Urological Medications Market Share Forecast by Country (2027-2032) Table 128. Europe Urological Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Urological Medications Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Urological Medications Market Share by Country (2021-2026) Table 131. Europe Urological Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Urological Medications Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Urological Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Urological Medications Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Urological Medications Market Share by Country (2021-2026) Table 136. Asia-Pacific Urological Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Urological Medications Market Share Forecast by Country (2027-2032) Table 138. Latin America Urological Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Urological Medications Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Urological Medications Market Share by Country (2021-2026) Table 141. Latin America Urological Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Urological Medications Market Share Forecast by Country (2027-2032) Table 143. Middle East & Africa Urological Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East & Africa Urological Medications Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East & Africa Urological Medications Market Share by Country (2021-2026) Table 146. Middle East & Africa Urological Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East & Africa Urological Medications Market Share Forecast by Country (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Urological Medications Product Image Figure 3. Global Urological Medications Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Urological Medications Market Size (2021-2032) & (US$ Million) Figure 5. Global Urological Medications Market Share by Region: 2025 VS 2032 Figure 6. Global Urological Medications Market Share by Region (2021-2032) Figure 7. North America Urological Medications Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Urological Medications Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Urological Medications Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Urological Medications Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Urological Medications Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Anticholinergics Image Figure 13. Global Anticholinergics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Alpha Blockers Image Figure 15. Global Alpha Blockers Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. 5-Alpha Inhibitors Image Figure 17. Global 5-Alpha Inhibitors Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Urological Medications Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Urological Medications Market Share by Type 2025 VS 2032 Figure 22. North America Urological Medications Market Size Share by Type (2021-2032) Figure 23. Europe Urological Medications Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Urological Medications Market Size Share by Type (2021-2032) Figure 25. Latin America Urological Medications Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Urological Medications Market Size Share by Type (2021-2032) Figure 27. OAB Image Figure 28. Global OAB Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. ED Image Figure 30. Global ED Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Prostate Cancer Image Figure 32. Global Prostate Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. BPH Image Figure 34. Global BPH Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. SUI Image Figure 36. Global SUI Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Others Image Figure 38. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Global Urological Medications Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Urological Medications Market Share by Application 2025 VS 2032 Figure 41. North America Urological Medications Market Size Share by Application (2021-2032) Figure 42. Europe Urological Medications Market Size Share by Application (2021-2032) Figure 43. Asia-Pacific Urological Medications Market Size Share by Application (2021-2032) Figure 44. Latin America Urological Medications Market Size Share by Application (2021-2032) Figure 45. Middle East and Africa Urological Medications Market Size Share by Application (2021-2032) Figure 46. Global Top 5 and 10 Urological Medications Players Market Share by Revenue in 2025 Figure 47. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 48. North America Urological Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. North America Urological Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. North America Urological Medications Market Share by Country (2021-2032) Figure 51. Europe Urological Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Urological Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Urological Medications Market Share by Country (2021-2032) Figure 54. Asia-Pacific Urological Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Asia-Pacific Urological Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Asia-Pacific Urological Medications Market Share by Country (2021-2032) Figure 57. Latin America Urological Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Urological Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Urological Medications Market Share by Country (2021-2032) Figure 60. Middle East & Africa Urological Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Middle East & Africa Urological Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 62. Middle East & Africa Urological Medications Market Share by Country (2021-2032) Figure 63. Years Considered Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Anticholinergics
  • Alpha Blockers
  • 5-Alpha Inhibitors
  • Others
Applications
  • OAB
  • ED
  • Prostate Cancer
  • BPH
  • SUI
  • Others
Companies covered
  • Abbott
  • Novartis
  • Merck
  • Lilly
  • Pfizer
  • GlaxoSmithKline
  • AbbVie
  • Viatris
  • Sanofi-aventis U.S. LLC
  • Piramal Pharma Solutions
  • Mallinckrodt
  • Endo International
  • Bayer HealthCare Pharmaceuticals
  • Astellas Pharma
  • ADVANZ PHARMA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Urological Medications Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Urological Medications Market Size by Region (2021-2032)
  5. 1.4.1 Global Urological Medications Market Size by Region (2021-2026)
  6. 1.4.2 Global Urological Medications Market Size by Region (2027-2032)
  7. 1.5 Key Regions Urological Medications Market Size (2021-2032)
  8. 1.5.1 North America Urological Medications Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Urological Medications Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Urological Medications Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Urological Medications Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Urological Medications Market Size Growth Rate (2021-2032)
2 Urological Medications Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Anticholinergics
  3. 2.1.2 Alpha Blockers
  4. 2.1.3 5-Alpha Inhibitors
  5. 2.1.4 Others
  6. 2.2 Global Urological Medications Market Size by Type
  7. 2.2.1 Global Urological Medications Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Urological Medications Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Urological Medications Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Urological Medications Market Size by Regions
  11. 2.3.1 North America Urological Medications Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Urological Medications Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Urological Medications Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Urological Medications Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Urological Medications Market Size Breakdown by Type (2021-2026)
3 Urological Medications Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 OAB
  3. 3.1.2 ED
  4. 3.1.3 Prostate Cancer
  5. 3.1.4 BPH
  6. 3.1.5 SUI
  7. 3.1.6 Others
  8. 3.2 Global Urological Medications Market Size by Application
  9. 3.2.1 Global Urological Medications Market Size Overview by Application (2021-2032)
  10. 3.2.2 Global Urological Medications Historic Market Size Review by Application (2021-2026)
  11. 3.2.3 Global Urological Medications Market Size Forecasted by Application (2027-2032)
  12. 3.3 Global Urological Medications Market Size by Regions
  13. 3.3.1 North America Urological Medications Market Size Breakdown by Application (2021-2026)
  14. 3.3.2 Europe Urological Medications Market Size Breakdown by Application (2021-2026)
  15. 3.3.3 Asia-Pacific Urological Medications Market Size Breakdown by Application (2021-2026)
  16. 3.3.4 South America Urological Medications Market Size Breakdown by Application (2021-2026)
  17. 3.3.5 Middle East and Africa Urological Medications Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Urological Medications Industry Trends
  2. 4.2 Urological Medications Industry Drivers
  3. 4.3 Urological Medications Industry Opportunities and Challenges
  4. 4.4 Urological Medications Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Urological Medications Revenue (2021-2026)
  2. 5.2 Global Urological Medications Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Urological Medications Key Company Headquarters & Area Served
  4. 5.4 Global Urological Medications Company, Product Type & Application
  5. 5.5 Global Urological Medications Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Urological Medications Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Urological Medications Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Urological Medications Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Abbott
  2. 6.1.1 Abbott Company Information
  3. 6.1.2 Abbott Business Overview
  4. 6.1.3 Abbott Urological Medications Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Abbott Urological Medications Product Portfolio
  6. 6.1.5 Abbott Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis Urological Medications Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Novartis Urological Medications Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck Urological Medications Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Merck Urological Medications Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 Lilly
  20. 6.4.1 Lilly Company Information
  21. 6.4.2 Lilly Business Overview
  22. 6.4.3 Lilly Urological Medications Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Lilly Urological Medications Product Portfolio
  24. 6.4.5 Lilly Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Urological Medications Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Urological Medications Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 GlaxoSmithKline
  32. 6.6.1 GlaxoSmithKline Company Information
  33. 6.6.2 GlaxoSmithKline Business Overview
  34. 6.6.3 GlaxoSmithKline Urological Medications Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 GlaxoSmithKline Urological Medications Product Portfolio
  36. 6.6.5 GlaxoSmithKline Recent Developments
  37. 6.7 AbbVie
  38. 6.7.1 AbbVie Company Information
  39. 6.7.2 AbbVie Business Overview
  40. 6.7.3 AbbVie Urological Medications Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 AbbVie Urological Medications Product Portfolio
  42. 6.7.5 AbbVie Recent Developments
  43. 6.8 Viatris
  44. 6.8.1 Viatris Company Information
  45. 6.8.2 Viatris Business Overview
  46. 6.8.3 Viatris Urological Medications Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Viatris Urological Medications Product Portfolio
  48. 6.8.5 Viatris Recent Developments
  49. 6.9 Sanofi-aventis U.S. LLC
  50. 6.9.1 Sanofi-aventis U.S. LLC Company Information
  51. 6.9.2 Sanofi-aventis U.S. LLC Business Overview
  52. 6.9.3 Sanofi-aventis U.S. LLC Urological Medications Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Sanofi-aventis U.S. LLC Urological Medications Product Portfolio
  54. 6.9.5 Sanofi-aventis U.S. LLC Recent Developments
  55. 6.10 Piramal Pharma Solutions
  56. 6.10.1 Piramal Pharma Solutions Company Information
  57. 6.10.2 Piramal Pharma Solutions Business Overview
  58. 6.10.3 Piramal Pharma Solutions Urological Medications Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Piramal Pharma Solutions Urological Medications Product Portfolio
  60. 6.10.5 Piramal Pharma Solutions Recent Developments
  61. 6.11 Mallinckrodt
  62. 6.11.1 Mallinckrodt Company Information
  63. 6.11.2 Mallinckrodt Business Overview
  64. 6.11.3 Mallinckrodt Urological Medications Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Mallinckrodt Urological Medications Product Portfolio
  66. 6.11.5 Mallinckrodt Recent Developments
  67. 6.12 Endo International
  68. 6.12.1 Endo International Company Information
  69. 6.12.2 Endo International Business Overview
  70. 6.12.3 Endo International Urological Medications Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Endo International Urological Medications Product Portfolio
  72. 6.12.5 Endo International Recent Developments
  73. 6.13 Bayer HealthCare Pharmaceuticals
  74. 6.13.1 Bayer HealthCare Pharmaceuticals Company Information
  75. 6.13.2 Bayer HealthCare Pharmaceuticals Business Overview
  76. 6.13.3 Bayer HealthCare Pharmaceuticals Urological Medications Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Bayer HealthCare Pharmaceuticals Urological Medications Product Portfolio
  78. 6.13.5 Bayer HealthCare Pharmaceuticals Recent Developments
  79. 6.14 Astellas Pharma
  80. 6.14.1 Astellas Pharma Company Information
  81. 6.14.2 Astellas Pharma Business Overview
  82. 6.14.3 Astellas Pharma Urological Medications Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Astellas Pharma Urological Medications Product Portfolio
  84. 6.14.5 Astellas Pharma Recent Developments
  85. 6.15 ADVANZ PHARMA
  86. 6.15.1 ADVANZ PHARMA Company Information
  87. 6.15.2 ADVANZ PHARMA Business Overview
  88. 6.15.3 ADVANZ PHARMA Urological Medications Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 ADVANZ PHARMA Urological Medications Product Portfolio
  90. 6.15.5 ADVANZ PHARMA Recent Developments
7 North America
  1. 7.1 North America Urological Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Urological Medications Market Size by Country (2021-2026)
  3. 7.3 North America Urological Medications Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Urological Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Urological Medications Market Size by Country (2021-2026)
  3. 8.3 Europe Urological Medications Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Urological Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Urological Medications Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Urological Medications Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Urological Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Urological Medications Market Size by Country (2021-2026)
  3. 10.3 South America Urological Medications Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Urological Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Urological Medications Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Urological Medications Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst